Implantable vaginal drug delivery system of zidovudine for site specific activity

Jayalakshmi Nath, BN Veda Hari, D Ramya Devi


The present work aims at the formulation of novel anti‐human immunodeficiency virus vaginal compactable inserts to enhance the pharmacological effects of zidovudine (AZT). Attempt was taken to design a dosage form, which provides
sustained release of the drug at the site of action so as to minimize the overall dose and dosing frequency that can reduce the risk of side‐effects. Different formulations of the vaginal compacts of AZT were prepared employing wet granulation method, utilizing several mucoadhesive polymers such as hydroxypropyl methyl cellulose (HPMC 5, 15, 50, 3000 cps) and methyl
cellulose (MC) at 20%, 30% and 40% concentrations. The formulations were evaluated and post‐compression parameters including drug content, swelling study, in vitro diffusion, dissolution and drug release kinetic studies. Instrumental analysis like differential scanning calorimetry as well as Fourier transform infrared spectroscopy were performed to find the change in thermal properties and the possible interactions between drug‐polymer, respectively. X‐ray diffraction study was also done to reveal the modification of crystalline nature of drug in the formulation. The compacts prepared by HPMC 50 cps (40%) exhibited the better results in terms of swelling with sustained drug release through the gelled layer. Regardless of good physicochemical parameters, MC did not display a good polymer of choice due to accumulation of spongy gelled blanket around the compact, which is not homogenous but stiff and brittle.

Full Text:



Available from:

hivaids/.[Last accessed on 2013 Feb 20].

Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv

Drug Deliv Rev 2005;57:1692‐712.

Vermani K, Garg S. The scope and potential of vaginal drug delivery.

Pharm Sci Technolo Today 2000;3:359‐64.

Available from: [Last accessed

on 2013 Feb 18].

das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm


Arkendu C, Benoy BB, Deepak A. Prolong release bioadhesive vaginal

film of anti‐HIV drug (zidovudine): Formulation and in vitro evaluation.

Int J Pharm Sci Res 2010;1:28‐37.

Arkendu C, Benoy BB, Lait K. Formulation, in vitro evaluation and

stability of prolong release anti‐HIV bioadhesive microencapsulated

vaginal gel. J Pharm Res 2010;3:183‐92.

Chatterjee A, Kumar L, Bhowmik BB, Gupta A. Microparticulated anti‐HIV

vaginal gel: In vitro‐in vivo drug release and vaginal irritation study.

Pharm Dev Technol 2011;16:466‐73.

Chatterjee A, Bhowmik BB, Thakur YS. Formulation, in vitro and in vivo

pharmacokinetics of anti‐HIV vaginal bioadhesive gel. J Young Pharm


Rakesh RS, Sridhar RP, Mahesh C, Ayesha SA, Agilandeswari D.

Formulation and evaluation of buccal mucoadhesive patches of

zidovudine. Contemp Investig Obs Pharm 2012;1:44‐8.

Sirisha VN, Kiran KY, Chinna EM. Formulation and evaluation of

lamivudine and zidovudine extended release tablets. Int J Res Pharm

Biomed Sci 2012;3:1759‐63.

Carvalho FC, Campos ML, Peccinini RG, Gremião MP. Nasal administration

of liquid crystal precursor mucoadhesive vehicle as an alternative

antiretroviral therapy. Eur J Pharm Biopharm 2013;84:219‐27.

Perioli L, Ambrogi V, Pagano C, Massetti E, Rossi C. New solid

mucoadhesive systems for benzydamine vaginal administration.

Colloids Surf B Biointerfaces 2011;84:413‐20.

Santos JV, Batista de Carvalho LA, Pina ME. The influence of the

compression force on zidovudine release from matrix tablets. AAPS

Pharm Sci Tech 2010;11:1442‐8.

Rohit B, Amitava G. Design and development of bioadhesive antifungal

vaginal tablet: Physiochemical characterization and in vitro evaluation.

Int J Pharm Technol 2011;3:2770‐85.

Leon L, Liberman HA, Kanig JL. The Theory and Practice of Industrial

Pharmacy. 3rd ed. 1987: Varghese Publishing House; Dadar Bombay,


Herbert AL, Leon L, Joseph BS. Pharmaceutical Dosage Forms: Tablets.

nd ed. USA: CRC Press; 1989.

Indian Pharmacopeia. Vol. I, II. Ghaziabad: Ministry of Health

and Family Welfare, Government of India, Indian Pharmacopeia

Commission; 2007.

Voorspoels J, Casteels M, Remon JP, Temmerman M. Local treatment

of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J

Obstet Gynecol Reprod Biol 2002;105:64‐6.

United States Pharmacopoeia. 27th ed., Vol. I, II. (USP 32 Revision and

NF). USP NF; 2009.United States Pharmacopoeial Conventions Maryland

‐1790 USA

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on

drug release from controlled drug delivery systems. Acta Pol Pharm


Ravi PR, Ganga S, Saha RN. Design and in vitro evaluation of zidovudine

oral controlled release tablets prepared using hydroxypropyl

methylcellulose. Chem Pharm Bull (Tokyo) 2008;56:518‐24.

Himansu BS, Sreenivas SA, Suddhasattya D, Himanshu S. Formulation

and evaluation of sustained release zidovudine matrix tablets. Int J

Pharm Pharm Sci 2011;3:32‐41.

Amitava G, Abhradeep S, Sujit D, Ghosh T. Studies on formulations and

design of zidovudine loaded particulated vaginal bioadhesive tablet.

Int J PharmTech Res 2011;3:82‐92.

Narayana RP, Prakash K, Rama RT, Lakshmi NM. Preparation of

zidovudine extended release matrix tablets with various controlled

release polymers: A feasibility study of granulation and compression.

Int J Pharm Sci Nanotechnol 2011;3:1230‐9.

Kar RK, Mohapatra S, Mohapatra P, Bhanja SB, Barik BB. Formulation

and statistical optimization of controlled release matrix tablet of

zidovudine. Asian J Chem 2010;22:1896‐906.

Gautam S, Mahaveer S. Review: In vitro drug release characterization

models. Int J Pharm Stud Res 2011;2:1‐8.

Rao KR, Senapati P, Das MK. Formulation and in vitro evaluation of

ethyl cellulose microspheres containing zidovudine. J Microencapsul


Ashok P, Sagar DV, Chandrakant GB. A quantitative analysis of zidovudine

containing formulation by FT‐IR and UV spectroscopy. Anal Methods


Deepika V, Sasikanth K. Formulation and in vitro release study

of zidovudine sustained release tablets. Int J Pharm Biol Arch




  • There are currently no refbacks.